Pfizer Canada gets Health Canada approval for Beqvez to treat haemophilia B
The approval was based on the open-label, single-arm Phase 3 BENEGENE-2 study in which a single dose of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
04 Jan 24
The approval was based on the open-label, single-arm Phase 3 BENEGENE-2 study in which a single dose of…
04 Jan 24
The amendment also consists of an amicable resolution to their commercial dispute and several other adjustments to improve…
04 Jan 24
K Health will work with Mayo Clinic to develop and test its bespoke preventative cardiology care technology
04 Jan 24
Only FDA-Approved As-Needed Treatment For The Approximately 6 Million Premenopausal Women Who Suffer From Hypoactive Sexual Desire Disorder
03 Jan 24
Roche will obtain exclusive global rights to develop, manufacture, and commercialise MediLink’s cancer drug candidate YL211, in exchange…
03 Jan 24
The collaboration is aimed at creating cloud-based clinical software tools that facilitate comprehensive decision-making for early-stage breast cancer…
03 Jan 24
Voyager and Novartis Pharma will work on potential gene therapies for Huntington’s disease and spinal muscular atrophy using…
03 Jan 24
Slimaglutide is a weight management supplement that uses 10 GLP-1 Receptor agonists and secretagogues to offer a natural…
03 Jan 24
In preclinical animal trials, the asset showed an excellent safety profile, quick and widespread biodistribution throughout the brain,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
03 Jan 24
Issuance of U.S. Patent No. 11,850,053 also covers a novel system and method for calculating accurate, real-time heart…